Temporin-1CEa LK2(5)

General Information


DRACP ID  DRACP00458

Peptide Name   Temporin-1CEa LK2(5)

Sequence  FKDLKKIANIINSIFKK

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic construct

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=44.7µM MTT assay 24h 1
BCaP-37 Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=83.49µM MTT assay 24h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=894.7µM MTT assay 24h 1

Hemolytic Activity  Human erythrocytes: LC50=1186 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00458

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C96H162N24O23

Absent amino acids  CEGHMPQRTVWY

Common amino acids  K

Mass  230607

Pl  10.98

Basic residues  5

Acidic residues  1

Hydrophobic residues  8

Net charge  4

Boman Index  -2078

Hydrophobicity  -9.41

Aliphatic Index  120.59

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23609760

Title  Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa

Doi 10.1007/s12272-013-0112-8

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_4538

DRACP is developed by Dr.Zheng's team.